Average loss during this window ranges from 5-10% of baseline weight, though individual variation remains wide
Because everyone's body and lifestyle are different, experiences may vary, but regular use alongside healthy habits can help you get the most out of your wellness journey.
Safe & Comfortable We priortize your safety and comfort
The peptide received FDA approval in June 2019 under the brand name Vyleesi for treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women, establishing it as a first-in-class medication with a novel mechanism distinct from all previous sexual dysfunction treatments
If it is cloudy, contains particles, or appears frozen, do not use it
Regular light exercise may also help your body acclimate to the metabolic changes that semaglutide triggers